Medicare Enrolled
Dr. Carol Salem, M.D.
Urology Physician · San Diego, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Salem from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Salem?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Salem
Dr. Carol Salem is an urology physician in San Diego, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Salem performed 5,745 Medicare services across 1,780 unique beneficiaries.
Between the years covered by Open Payments, Dr. Salem received a total of $12,615 from 54 pharmaceutical and/or device companies across 293 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Salem is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 17% volume in CA
$12,615 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,745
Medicare services
Top 17% in CA for urology physician
1,780
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~302 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 2,248 | $2 | $10 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
734 | $50 | $300 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
723 | $2 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
335 | $63 | $439 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
255 | $66 | $440 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
240 | $42 | $279 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
177 | $0 | $2 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
145 | $36 | $280 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
100 | $201 | $1,230 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
97 | $12 | $80 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
87 | $73 | $430 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
87 | $99 | $600 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
85 | $144 | $840 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
66 | $8 | $59 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
63 | $40 | $270 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
53 | $100 | $593 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
46 | $921 | $5,234 |
| Bladder biopsy using endoscope A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities. |
35 | $107 | $949 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
32 | $51 | $170 |
| Complicated insertion of bladder tube | 28 | $127 | $729 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $143 | $616 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
24 | $14 | $120 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
23 | $81 | $540 |
| New patient office visit, complex (60-74 min) | 20 | $186 | $1,020 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $127 | $780 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,615
Total received (2018-2024)
Avg $1,802/year across 7 years
Top 16% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
293
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,210 (96.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$405 (3.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$856
2023
$4,744
2022
$1,116
2021
$1,107
2020
$684
2019
$3,275
2018
$833
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$177
ABBVIE INC.
$148
Janssen Biotech, Inc.
$89
Sumitomo Pharma America, Inc.
$68
Axonics, Inc.
$57
AstraZeneca Pharmaceuticals LP
$52
Davol Inc.
$34
MIMEDX Group, Inc.
$31
Ethicon US, LLC
$26
COLOPLAST CORP
$24
Endo USA, Inc.
$24
Teleflex LLC
$24
E.R. Squibb & Sons, L.L.C.
$23
Boston Scientific Corporation
$22
ACCORD HEALTHCARE, INC.
$21
Telix Pharmaceuticals
$20
Olympus America Inc.
$18
Top 3 companies account for 48.2% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$6,362
Astellas Pharma US Inc
$559
Axonics, Inc.
$474
Endo Pharmaceuticals Inc.
$394
PROCEPT BioRobotics Corporation
$369
Coloplast Corp
$346
Teleflex LLC
$346
Myriad Genetic Laboratories, Inc.
$261
Janssen Biotech, Inc.
$258
ABBVIE INC.
$206
NeoTract Inc.
$192
PFIZER INC.
$185
INTUITIVE SURGICAL, INC.
$177
Laborie Medical Technologies Corp.
$157
COLOPLAST CORP
$141
Photocure Inc
$133
180 Medical, Inc.
$132
Sumitomo Pharma America, Inc.
$128
Travere Therapeutics, Inc.
$126
Boston Scientific Corporation
$124
Antares Pharma, Inc.
$123
Avadel Specialty Pharmaceuticals, LLC
$101
UROGEN PHARMA, INC.
$96
Myovant Sciences Inc.
$95
AstraZeneca Pharmaceuticals LP
$93
Palette Life Sciences, Inc.
$75
AbbVie, Inc.
$72
Allergan, Inc.
$71
Telix Pharmaceuticals
$64
Bayer HealthCare Pharmaceuticals Inc.
$58
Progenics Pharmaceuticals, Inc.
$54
AbbVie Inc.
$52
ACCORD HEALTHCARE, INC.
$51
Rochester Medical Corporation
$51
Merck Sharp & Dohme LLC
$47
Davol Inc.
$34
MIMEDX Group, Inc.
$31
Blue Earth Diagnostics Limited
$28
Ethicon US, LLC
$26
ConvaTec Inc.
$25
Amgen Inc.
$25
UROVANT SCIENCES INC
$25
Bayer Healthcare Pharmaceuticals Inc.
$24
Merck Sharp & Dohme Corporation
$24
DENTSPLY IH Inc.
$24
PALETTE LIFE SCIENCES, INC.
$24
UroGen Pharma, Inc.
$24
Endo USA, Inc.
$24
E.R. Squibb & Sons, L.L.C.
$23
Retrophin, Inc.
$19
Olympus America Inc.
$18
ABC Home Medical Supply, Inc.
$17
Ferring Pharmaceuticals Inc.
$15
Acerus Pharmaceuticals Corporation
$12
Top 3 companies account for 58.6% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · CAMCEVI · CONTINENCE CARE · CURE CATHETER · CYSVIEW · Cysview · Da Vinci Surgical System · EDEX · ERLEADA · Erleada · GEMTESA · GENTLECATH · GentleCath · ILLUCCIX · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · LoFric · Lupron · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Otrexup · PROLARIS · PYLARIFY · Phasix Mesh · Prolaris · REZUM · ROCHESTER MAGIC3 · Rezum Generator · SPEEDICATH · SenSura Mio · SpeediCath · TOVIAZ · Thiola · Titan · UROLIFT · UroLift · UroLift System · VISTASEAL · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
131
Per 100K population
4.0
County median income
$102,285
Nearest hospital
UC SAN DIEGO HEALTH HILLCREST - HILLCREST MED CTR
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Salem is a clinical cardiology specialist, with above-average Medicare volume (top 17% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Salem experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Salem performed 2,248 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Salem receive payments from pharmaceutical companies?
Yes. Dr. Salem received a total of $12,615 from 54 companies across 293 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Salem's costs compare to other urology physicians in San Diego?
Dr. Salem's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Salem) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in San Diego
Browse urology physicians in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology